Cladribine as treatment of multiple sclerosis, real world experience

被引：0
|
作者：
Celius, E. G.
Berg-Hansen, P.
机构：
[1] Univ Oslo, Oslo Univ Hosp Ulleval, Neurol, Oslo, Norway
[2] Univ Oslo, Inst Clin Med, Oslo, Norway
来源：
MULTIPLE SCLEROSIS JOURNAL | 2019年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P998
引用
收藏
页码：527 / 528
页数：2
相关论文
共 50 条
  • [1] Cladribine use in multiple sclerosis: a monocentric real-world experience
    Pilotto, Silvy
    Mellino, Paolo
    Carmagnini, Daniele
    Frau, Jessica
    Coghe, Giancarlo
    Cocco, Eleonora
    Lorefice, Lorena
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 639 - 640
  • [2] Real world experience with cladribine tablets for multiple sclerosis at four academic multiple sclerosis centers
    Conway, Devon S.
    Nicholas, Jacqueline A.
    Thompson, Nicolas R.
    Mowry, Ellen M.
    Naismith, Robert T.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2025, 94
  • [3] Real World Experience With Early Treatment With Cladribine in Mild-Moderate Relapsing Multiple Sclerosis
    Rodriguez-Jorge, F.
    Sainz de la Maza, S.
    Chico-Garcia, J.
    Sainz-Amo, R.
    Fernandez-Velasco, J.
    Villar, L.
    Masjuan, J.
    Costa-Frossard, L.
    Monreal, E.
    EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 : 648 - 648
  • [4] Real world experience with cladribine tablets in the management of relapsing multiple sclerosis in Qatar
    Canibano, Beatriz Garcia
    Okar, Lina
    Baniamer, Yahya Zakarya
    Deleu, Dirk
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2024, 247
  • [5] Real world study of Cladribine in relapsing remitting multiple sclerosis, Kuwait experience
    Mohamed, Samar Farouk Ahmed
    Al Hashel, Jassem
    Almojel, MalaK
    Alroughani, Raed
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 1105 - 1105
  • [6] Immunological consequences of cladribine treatment in multiple sclerosis: A real-world study
    Rolfes, Leoni
    Pfeuffer, Steffen
    Huntemann, Niklas
    Schmidt, Mariella
    Su, Chuanxin
    Skuljec, Jelena
    Aslan, Derya
    Hackert, Jana
    Kleinschnitz, Konstanze
    Hagenacker, Tim
    Pawlitzki, Marc
    Ruck, Tobias
    Kleinschnitz, Christoph
    Meuth, Sven G.
    Pul, Refik
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2022, 64
  • [7] Immunological consequences of cladribine treatment in multiple sclerosis: a real-world study
    Rolfes, L.
    Pfeuffer, S.
    Huntemann, N.
    Schmidt, M.
    Su, C.
    Skuljec, J.
    Aslan, D.
    Hackert, J.
    Kleinschnitz, K.
    Hagenacker, T.
    Pawlitzki, M.
    Ruck, T.
    Kleinschnitz, C.
    Meuth, S. G.
    Pul, R.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 332 - 333
  • [8] Real world experience with cladribine treatment in Slovakia
    Kantorova, E.
    Szilasiova, J.
    Vitkova, M.
    Jankovicova, N.
    Kahancova, E.
    Tarcak, M.
    Fedicova, M.
    Michalik, J.
    Kurca, E.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 862 - 863
  • [9] Real world experience of oral immune reconstitution therapy (cladribine) in the treatment of multiple sclerosis in the united arab emirates
    Thakre, M.
    Inshasi, J.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 185 - 185
  • [10] Real-world experience of cladribine treatment in relapsing-remitting multiple sclerosis: A Danish nationwide study
    Sorensen, Per Soelberg
    Pontieri, Luigi
    Joensen, Hanna
    Heick, Alex
    Rasmussen, Peter Vestergaard
    Schafer, Jakob
    Ratzer, Rikke
    Pihl, Caroline Ellinore
    Sellebjerg, Finn
    Magyari, Melinda
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2023, 70
12345